Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2147
Peer-review started: July 14, 2021
First decision: August 8, 2021
Revised: September 21, 2021
Accepted: January 25, 2022
Article in press: January 25, 2022
Published online: March 6, 2022
Processing time: 230 Days and 11.7 Hours
Diabetes mellitus (DM) rates in the United States have been increasing and women with diabetes in pregnancy have high rates of congenital anomalies, preeclampsia, preterm delivery, macrosomia, and perinatal mortality. In the United States, approximately seven percent of pregnancies are affected by DM, a condition in which a woman’s blood glucose levels are above normal. The effect of insulin resistance on birth outcomes has been well documented. There is an important gap in the published literature, however, regarding population level studies of diabetes during pregnancy. For example, several large cohort studies of birth certificate data have reported an association between diabetes and birth outcomes, although differences in birth outcomes between diabetes types have rarely been reported.
Understanding the differential impact of prepregnancy diabetes with and without insulin dependence and GDM can offer important clues to understanding the population impact of insulin dependence on birth outcomes in the United States. This study explores how birth outcomes vary for women exposed based upon timing of diabetes (pre-gestational or gestational) and insulin-dependence, building upon previous studies by including potentially important confounders like BMI (a reliable measure for population-based surveillance).
To investigate differences in birth outcomes (preterm birth, macrosomia, and infant mortality/) by diabetes status.
Cross-sectional design, using linked Missouri birth and death certificates [singleton births only), 2010 to 2012 (n = 204057). Exposure was diabetes (non-diabetic, pre-pregnancy diabetes-insulin dependent (PD-I), pre-pregnancy diabetes-non-insulin dependent (PD-NI), gestational diabetes- insulin dependent (GD-I), and gestational diabetes-non-insulin dependent (GD-NI)]. Outcomes included preterm birth, macrosomia, and neonatal death. Confounders included demographic characteristics, adequacy of prenatal care, BMI, smoking, hypertension, and previous preterm birth. Bivariate and multivariate logistic regression assessed differences in outcomes by diabetes status.
Women with PD-I, PD-NI, and GD-I remained at a significantly increased odds for preterm birth (aOR 2.87; aOR 1.77; and aOR 1.73, respectively) and having a very large baby (macrosomia) (aOR 3.01, aOR 2.12; aOR and 1.96;, respectively); in reference to non-diabetic women. Women with GD-NI were at a significantly increased risk for macrosomia (aOR1.53), decreased risk for their baby to die before their first birthday (aOR 0.41) and no difference in risk for preterm birth in reference to non-diabetic women.
As categories of diabetes differed, so too did risk for poor birth outcomes, with having insulin use among women with pre-pregnancy diabetes putting women at the highest risk for the poorest birth outcomes.
Diabetes is associated with the poor birth outcomes. Clinical management of diabetes during pregnancy and healthy lifestyle behaviors before pregnancy can reduce the risk for diabetes and poor birth outcomes.